Peter E. Boyd - 05 Sep 2025 Form 4 Insider Report for Aquestive Therapeutics, Inc. (AQST)

Reporting relationship: SVP IT, HR, & Communications
Issuer ticker: AQST
Reported as of: 05 Sep 2025
Net transaction value: -$79,500
SEC form: 4
Accepted by SEC: 08 Sep 2025, 17:13:13 UTC
Prior SEC filing: 13 Apr 2026
Next SEC filing: 29 Sep 2025
Source filing: View source filing
Reporting owner signature: /s/ Lori Braender, as Attorney-In-Fact

Key filing fact

Peter E. Boyd filed Form 4 for Aquestive Therapeutics, Inc. (AQST) on 08 Sep 2025.

Key facts

This page summarizes Peter E. Boyd's Form 4 filing for Aquestive Therapeutics, Inc. (AQST).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 08 Sep 2025, 17:13.

Change

Previous filing in this sequence was filed on 13 Apr 2026.
Current net transaction value: -$79,500.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001739816 Primary reporting owner

Boyd Peter E.

Relationship: SVP IT, HR, & Communications
Address: C/O AQUESTIVE THERAPEUTICS, INC., 30 TECHNOLOGY DRIVE, WARREN
Signature: /s/ Lori Braender, as Attorney-In-Fact
Signature date: 08 Sep 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AQST transaction

Common Stock

Sale

Transaction value: $79,500
Shares: -15,000
Change %: -4.9%
Price: $5.30
Shares after: 288,323
Date: 05 Sep 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 1 footnote

Footnote F1

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4.

SEC remarks

SVP IT, HR, & Communications